Uloric Prescribing Information

Author:

Takeda Pharmaceuticals America, Inc.

Title:

Uloric Prescribing Information

Published:

Feb 2009.

Highlights page, followed by full prescribing information, including gout patient information for the febuxostat drug marketed as Uloric.

Febuxostat Versus Allopurinol

Author:

Reinders MK, Jansen TL.

Title:

Management of hyperuricemia in gout: focus on febuxostat.

Published:

Clin Interv Aging. 2010 Feb 2;5:7-18.

Review of febuxostat, with particular emphasis on the comparison with allopurinol as a gout treatment.

Febuxostat Review

Author:

Hu M, Tomlinson B.

Title:

Febuxostat in the management of hyperuricemia and chronic gout: a review.

Published:

Ther Clin Risk Manag. 2008 Dec;4(6):1209-20.

Comprehensive review of the properties of febuxostat and it’s application as a gout treatment following release in Europe under the brand name Adenuric.

Febuxostat Briefing Material

Briefing Document for Febuxostat. Nov 2008. Takeda Pharmaceuticals North America, Inc. Comprehensive review of studies carried out to support the application for febuxostat, released under the brand name Uloric (Adenuric outside USA).